. 2019 Aug;10(4):766–776. doi: 10.21037/jgo.2019.03.07

Table 2. The effect of different treatment cycles on serum levels of IL-10 and some biochemical parameters.

Parameter	At baseline	After one cycle	After two cycles	After three cycles	P value between groups
ALT (U/L)	57.50 (44.25–83.25)	52.50 (41.25–77.50)^a	54.05±16.23^a,b	44.47±10.27^a,b	<0.001
AST (U/L)	76.65±23.51	70.35±20.63^a	61.05±18.69^a,b	46.60±12.39^a,b,c	<0.001
Albumin (g/dL)	2.85 (2.70–3.30)	2.98±0.48	3.06±0.44	3.10 (2.90–3.60)^a,b	0.003
Total bilirubin (mg/dL)	1.84±0.77	1.67±0.63	1.36±0.52^a,b	1.02±0.27^a,b,c	<0.001
AFU (U/L)	610 (502.5–755.25)	461.10±150.89^a	280 (207.0–395.0)^a	205 (125.0–287.0)^a,b,c	<0.001
IL-10 (pg/mL)	35.79±9.54	32.74±6.12	26.89±5.18^a,b	22.44 (17.98–26.84)^a,b,c	<0.001

Data are expressed as mean ± SD for Gaussian variables and median (inter-quartile range) for non-Gaussian variables. In multiple comparisons: ^a, P<0.05 vs. baseline; ^b, P<0.05 vs. first cycle; ^c, P<0.05 vs. second cycle. ALT, alanine aminotransferase; AST, aspartate aminotransferase; AFU, alpha-L-fucosidase; IL-10, interleukin-10.